SCOPUS 정보 검색 플랫폼

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

Cost effectiveness of Iran national plasma contract fractionation program

(1) Cheraghali, Abdol Majid a

a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES (Iran)

Author keywords

Blood transfusion service; Cost effectiveness; Iran; Plasma contract fractionation

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN;

BLOOD DONOR; BLOOD TRANSFUSION; COST; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; FRACTIONATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEMOPHILIA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IRAN; PLASMA CONTRACT FRACTIONATION PROGRAM; REVIEW; SYPHILIS;

EID: 84871196085 PISSN: 15608115 EISSN: 20082231 Source Type: Journal
DOI: 10.1186/2008-2231-20-63 Document Type: Review

Times cited : (9)

References (13)

1
- 84858285271
- Worldwide supply and demand of plasma and plasma-derived medicines
- Worldwide supply and demand of plasma and plasma-derived medicines. Robert P, Iran J Blood Cancer 2011 3 111 120
- (2011) Iran J Blood Cancer , vol.3 , pp. 111-120
- Robert, P.¹

2
- 84871221581
- Plasma fractionation in Asia-Pacific: Challenges and perspectives
- 10.1111/j.1751-2824.2011.01517.x
- Plasma fractionation in Asia-Pacific: challenges and perspectives. Burnouf T, ISBT Sci Series 2011 6 366 372 10.1111/j.1751-2824.2011.01517.x
- (2011) ISBT Sci Series , vol.6 , pp. 366-372
- Burnouf, T.¹

3
- 84865166712
- Plasma derived medicines: Access and usage issues
- 22244007
- Plasma derived medicines: access and usage issues. Farrugia A, Cassar J, Blood Transfus 2012 10 273 8 22244007
- (2012) Blood Transfus , vol.10 , pp. 273-278
- Farrugia, A.¹ Cassar, J.²

4
- 84871221605
- World Federation of Hemophilia http://www1.wfh.org/publications/files/ pdf-1427.pdf
- World Federation of Hemophilia, World Federation of Hemophilia Report on the Annual Global Survey 2010 http://www1.wfh.org/publications/files/pdf-1427. pdf
- (2010) World Federation of Hemophilia Report on the Annual Global Survey

5
- 84871224445
- Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe
- Available at: http://www.info4pi.org/Documents/Publications/Primary- Immunodeficiencies-%28PID%29-European-Reference-Paper-2010-20100705-104140.pdf
- European Reference Paper, Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe. 2010 Available at: http://www.info4pi.org/ Documents/Publications/Primary-Immunodeficiencies-%28PID%29-European-Reference- Paper-2010-20100705-104140.pdf
- (2010) Primary Immunodeficiencies (PID) Driving Diagnosis for Optimal Care in Europe

6
- 84871240977
- World health organization Available at: http://www.who.int/mediacentre/ factsheets/fs279/en/index.html
- World health organization, Blood safety and availability 2012 Available at: http://www.who.int/mediacentre/factsheets/fs279/en/index.html
- (2012) Blood Safety and Availability

7
- 77956644801
- World health organization http://apps.who.int/gb/ebwha/pdf-files/WHA63/ A63-20-en.pdf
- World health organization, Availability, safety and quality of blood products 2010 http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-20-en.pdf
- (2010) Availability, Safety and Quality of Blood Products

8
- 77649180333
- Improving availability and affordability of plasma derived medicines
- 10.1016/j.biologicals.2009.10.004 20137973
- Improving availability and affordability of plasma derived medicines. Cheraghali AM, Abolghasemi H, Biologicals 2010 38 81 86 10.1016/j.biologicals. 2009.10.004 20137973
- (2010) Biologicals , vol.38 , pp. 81-86
- Cheraghali, A.M.¹ Abolghasemi, H.²

9
- 63349090315
- Plasma fractionation a useful mean to improve national transfusion system and blood safety: Iran experience
- 10.1111/j.1365-2516.2008.01936.x 19347989
- Plasma fractionation a useful mean to improve national transfusion system and blood safety: Iran experience. Cheraghali AM, Abolghasemi H, Haemophilia 2009 15 487 493 10.1111/j.1365-2516.2008.01936.x 19347989
- (2009) Haemophilia , vol.15 , pp. 487-493
- Cheraghali, A.M.¹ Abolghasemi, H.²

10
- 84867499500
- Overview of blood transfusion system of iran: 2002-2011
- 23113231
- Overview of Blood Transfusion System of Iran: 2002-2011. Cheraghali AM, Iran J Public Health 2012 41 89 93 23113231
- (2012) Iran J Public Health , vol.41 , pp. 89-93
- Cheraghali, A.M.¹

11
- 0037293170
- The Norwegian plasma fractionation project a 12 year clinical and economic success story
- 10.1016/S1473-0502(02)00104-0 12620274
- The Norwegian plasma fractionation project- a 12 year clinical and economic success story. Flesland O, Seghatchian J, Solheim BG, Transfus Apher Sci 2003 28 93 100 10.1016/S1473-0502(02)00104-0 12620274
- (2003) Transfus Apher Sci , vol.28 , pp. 93-100
- Flesland, O.¹ Seghatchian, J.² Solheim, B.G.³

12
- 72449185201
- Economical impact of plasma fractionation project in iran on affordability of plasma derived medicines
- 10.1111/j.1365-3148.2009.00961.x 19778319
- Economical Impact of Plasma Fractionation Project in Iran on Affordability of Plasma Derived Medicines. Cheraghali AM, Aboofazeli R, Transfus Med 2009 19 363 368 10.1111/j.1365-3148.2009.00961.x 19778319
- (2009) Transfus Med , vol.19 , pp. 363-368
- Cheraghali, A.M.¹ Aboofazeli, R.²

13
- 85013616634
- Plasma proteins: Unique biopharmaceuticals-unique economics
- Plasma proteins: unique biopharmaceuticals-unique economics. Burnouf T, Pharmaceutic Policy Law 2005-2006 7 209 218
- (2005) Pharmaceutic Policy Law , vol.7 , pp. 209-218
- Burnouf, T.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.